Calcium Polystyrene Sulfonate

聚苯乙烯磺酸钙

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCalcium Polystyrene Sulfonate
Drug Alias NameCalcium Polystyrene Sulphonate聚磺苯乙烯钙聚苯乙烯磺酸钙ARGAMATE可利美特 +[9] 
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionMuscle-type nicotinic acetylcholine receptor agonists
TargetsMuscle-type nicotinic acetylcholine receptor
Therapy Area/IndicationsHyperkalemia
Global Approved IndicationsHyperkalemia
Approved Indications in ChinaHyperkalemia
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca PlcNo 3 Yuncheng St Economic Development Zone
Inactive CompaniesN/A
Active IndicationsHyperkalemia
Inactive IndicationsN/A

Other Information

ATC CodeV03AE01
Related LinksWikipediaDrugBankKEGG